{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:05Z","timestamp":1791118745204,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1053\/j.ajkd.2013.03.045","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T20:01:38Z","timestamp":1371240098000},"page":"1012-1017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Membranous Nephropathy and Nonsteroidal Anti-inflammatory Agents"],"prefix":"10.1053","volume":"62","author":[{"given":"Fareha A.","family":"Nawaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Troxell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1053\/j.ajkd.2013.03.045_bib1","first-page":"64","article-title":"Secondary membranous glomerulonephritis","volume":"1","author":"Glassock","year":"1992","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2013.03.045_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-Type phospholipase A2 receptor as a target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2013.03.045_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/modpathol.2012.207","article-title":"Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies","volume":"26","author":"Larsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.ajkd.2013.03.045_bib4","series-title":"Atlas of Non-Tumor Pathology: Non-Neoplastic Kidney Diseases","first-page":"161","article-title":"Membranous glomerulopathy","author":"D'Agati","year":"2005"},{"key":"10.1053\/j.ajkd.2013.03.045_bib5","series-title":"Heptinstall's Pathology of the Kidney","first-page":"205","article-title":"Membranous glomerulonephritis","author":"Schwartz","year":"2007"},{"issue":"3","key":"10.1053\/j.ajkd.2013.03.045_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfg616","article-title":"Distribution of glomerular IgG subclass deposits in malignancy associated membranous nephropathy","volume":"19","author":"Ohtani","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2013.03.045_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc. Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2013.03.045_bib8","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","article-title":"Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy","volume":"27","author":"Qu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2013.03.045_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2013.03.045_bib10","first-page":"228","article-title":"Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs","volume":"15","author":"Kleinknecht","year":"1995","journal-title":"Semin Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2013.03.045_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5414\/CNP59137","article-title":"Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib","volume":"59","author":"Markowitz","year":"2003","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2013.03.045_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.1996.03540060042033","article-title":"Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs","volume":"276","author":"Radford","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2013.03.045_bib13","first-page":"279","article-title":"Membranous nephropathy associated with flurbiprofen","volume":"47","author":"Mackay","year":"1997","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2013.03.045_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000189356","article-title":"Membranous nephropathy associated with oxaprozin treatment","volume":"74","author":"Ogawa","year":"1996","journal-title":"Nephron"},{"issue":"1","key":"10.1053\/j.ajkd.2013.03.045_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinte.1984.00350130069014","article-title":"Piroxicam-induced renal disease","volume":"144","author":"Mitnick","year":"1984","journal-title":"Arch Intern Med"},{"issue":"13","key":"10.1053\/j.ajkd.2013.03.045_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2169\/internalmedicine.46.0094","article-title":"Membranous nephropathy associated with the relatively selective cyclooxygenase-2 inhibitor, etodolac, in a patient with early rheumatoid arthritis","volume":"46","author":"Sugimoto","year":"2007","journal-title":"Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2013.03.045_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF03256934","article-title":"Safe administration of celecoxib to a patient with repeated episodes of nephrotic syndrome induced by NSAIDs","volume":"31","author":"Mihovilovic","year":"2011","journal-title":"Clin Drug Investig"},{"issue":"9","key":"10.1053\/j.ajkd.2013.03.045_bib18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"7","author":"Murtas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.03.045_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ki.2012.382","article-title":"Membranous glomerulonephritis is a manifestation of IgG4-related disease","volume":"83","author":"Alexander","year":"2013","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2013.03.045_bib20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2013.03.045_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ncpneph0854","article-title":"A primer on recurrent and de novo glomerulonephritis in renal allografts","volume":"4","author":"Ivanyi","year":"2008","journal-title":"Nat Clin Pract Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613008123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613008123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:09:49Z","timestamp":1759457389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638613008123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0272638613008123"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.045","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membranous Nephropathy and Nonsteroidal Anti-inflammatory Agents","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}